Legend Biotech CorporationLEGNNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P100
Near historical high
vs 2Y Ago
8.8x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 320.83% |
| Q2 2025 | 87.43% |
| Q1 2025 | -26.41% |
| Q4 2024 | -8.25% |
| Q3 2024 | -4492.49% |
| Q2 2024 | -110.64% |
| Q1 2024 | 116.22% |
| Q4 2023 | -57.19% |
| Q3 2023 | 36.44% |
| Q2 2023 | 31.24% |
| Q1 2023 | -179.87% |
| Q4 2022 | 31.02% |
| Q3 2022 | -9644.86% |
| Q2 2022 | 99.06% |
| Q1 2022 | -13.14% |
| Q4 2021 | -55.96% |
| Q3 2021 | 22.50% |
| Q2 2021 | -114.80% |
| Q1 2021 | 52.13% |
| Q4 2020 | 13.08% |
| Q3 2020 | -13.16% |
| Q2 2020 | -24.21% |
| Q1 2020 | 23.66% |
| Q4 2019 | -400.73% |
| Q3 2019 | 151.45% |
| Q2 2019 | -810.21% |
| Q1 2019 | 0.00% |